Expanding the applicability of noninvasive fibrosis markers in HIV/HCV co-infected patients.
Schiavon
Leonardo L
LL
Filho
Roberto J Carvalho
RJ
Narciso
Janaína L
JL
Sampaio
Juliana P
JP
Lanzoni
Valéria P
VP
Ferraz
Maria Lucia G
ML
Silva
Antonio Eduardo B
AE
D000367:Age Factors; D000410:Alanine Transaminase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D015415:Biomarkers / Q000097:blood*; D015658:HIV Infections / Q000150:complications*; D006526:Hepatitis C / Q000150:complications*; D006801:Humans; D008103:Liver Cirrhosis / Q000097:blood / Q000175:diagnosis* / Q000209:etiology* / Q000503:physiopathology; D010976:Platelet Count; D011379:Prognosis; D012720:Severity of Illness Index
D015415:Biomarkers; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase